Tagged idiopathic-pulmonary-fibrosis

Press Release

Elixiron Immunotherapeutics Announces Orphan Drug Designation Granted to CSF-1R Inhibitor, EI-1071 for the Treatment of Idiopathic Pulmonary Fibrosis

 Read More
PharmaNest Announces Kidney and Lung Fibrosis Quantification Data to Be Presented at the 2020 Fibrosis and Tissue Repair Keystone Symposium
Press Release

PharmaNest Announces Kidney and Lung Fibrosis Quantification Data to Be Presented at the 2020 Fibrosis and Tissue Repair Keystone Symposium

 New image analysis data of tissues with FibroNest™ is presented for the continuous assessment of the severity and progression of fibrosis in Kidney and Lung preclinical models at the Fibrosis and Tissue Repair 2020 Keystone Symposium. FibroNest image analysis tool provides the most advanced cloud-based phenotypic image analysis and translational platform for the automated quantification of fibrosis across multiple fibrotic conditions and organs for drug discovery and drug development projects. Read More
A New Target for the Treatment of Idiopathic Pulmonary Fibrosis
Press Release

A New Target for the Treatment of Idiopathic Pulmonary Fibrosis

 Read More
Academy of Continued Healthcare Learning, ProPatient, and ArcheMedX Extend Collaboration to Improve Shared Decision Making in Patient Care
Press Release

Academy of Continued Healthcare Learning, ProPatient, and ArcheMedX Extend Collaboration to Improve Shared Decision Making in Patient Care

 Pilot programs demonstrate that digital learning increases physician engagement and empowers patients to self-advocate Read More
Idiopathic Pulmonary Fibrosis: Partnering With Your Doctor
Press Release

Idiopathic Pulmonary Fibrosis: Partnering With Your Doctor

 New online resource for patients living with Idiopathic Pulmonary Fibrosis (IPF) Read More